Cabergoline (Australia) — Patient-Friendly Medicine Information

Cabergoline is a prescription medicine used for several conditions related to hormone imbalance, particularly elevated prolactin. It belongs to a class of medicines called dopamine agonists. This page explains what cabergoline is, how it works, what it’s used for, how to take it safely, and what to expect during treatment. It is written for general information and is not a substitute for advice from a healthcare professional.

Basic Product Information

Important note: Brand names and strengths vary. Always confirm you have the correct dose and tablet strength, and follow the dosing instructions provided by your treating clinician.

How Cabergoline Works (Mechanism of Action)

Cabergoline works by stimulating dopamine receptors in the brain. Dopamine is a natural chemical messenger that helps regulate hormone release.

• Prolactin reduction: By activating dopamine pathways, cabergoline reduces prolactin secretion from the pituitary gland.
• Effects on tumour growth (when applicable): For some pituitary prolactin-secreting tumours, reducing prolactin can also reduce tumour size over time.
• Why it may be effective: Compared with some other therapies, cabergoline is often effective at lowering prolactin and may be taken less frequently due to its longer duration of action.

Pharmacokinetics (How the Body Handles Cabergoline)

Pharmacokinetics describes absorption, distribution, metabolism, and elimination. While individual responses vary, the general pattern is:

• Absorption: Cabergoline is absorbed after oral administration.
• Onset: Hormone-related effects may begin within days, but prolactin levels and symptoms may take weeks to stabilise.
• Distribution: It distributes into body tissues, including the central nervous system.
• Metabolism: Cabergoline is metabolised mainly in the liver through enzymatic pathways.
• Elimination: Metabolites are eliminated primarily through the body’s usual clearance processes (including the biliary route and urine).

Long duration: Cabergoline’s effects last longer than many daily medicines, which is why dosing schedules commonly use weekly regimens for many prolactin-related conditions.

Typical Use and Indications

Cabergoline is commonly used to treat problems caused by high prolactin (hyperprolactinaemia) and related conditions. It may be used when:

• Hyperprolactinaemia is causing symptoms such as menstrual irregularities, infertility, or sexual dysfunction.
• Prolactin-secreting pituitary adenomas (prolactinomas) are present, to reduce prolactin levels and, in some cases, reduce tumour size.
• Other specific endocrine situations where a specialist considers dopamine agonist therapy appropriate.

Use in women and men: Cabergoline may be used in both men and women depending on the underlying cause and symptom profile.

When to Take Cabergoline (Timing and Scheduling)

Timing depends on your exact dosing plan and tablet strength. Many people take cabergoline on a once-weekly or twice-weekly schedule.

General guidance

• Choose a consistent day/time each week.
• With food or without: Cabergoline can generally be taken with or without food. If nausea occurs, taking it with food may help.
• Try to take it at a time you can rest if you feel light-headed during the initial weeks.

If you miss a dose

• If you miss a dose, take it when you remember unless it is close to your next scheduled dose.
• Do not double up to make up for the missed dose.
• Because dosing is often weekly, the best approach can vary—check with your pharmacist or clinician for what to do in your specific situation.

Food Interactions

Food interactions can influence how comfortable you feel after taking medication. For cabergoline:

• Normal meals: It is usually possible to take cabergoline with or without food.
• Gastrointestinal comfort: If you experience nausea or stomach upset, try taking it with food on future doses (if your prescriber/pharmacist agrees).

Practical tip: Avoid large, very heavy meals right before your dose if you tend to feel nauseated.

Alcohol and Medicine Interactions

Alcohol may worsen dizziness, drowsiness, and impairment of reaction time. Because cabergoline can also affect alertness in some people, alcohol can increase the likelihood of unwanted effects.

Alcohol

• Limit or avoid alcohol until you know how cabergoline affects you.
• If you choose to drink, do so cautiously and avoid binge drinking.

Medicines that may interact

Cabergoline can interact with other medicines, particularly those affecting the brain’s dopamine system or those that lower blood pressure.

• Blood pressure medicines: Cabergoline may cause lower blood pressure in some people, which may add to the effect of antihypertensive drugs.
• Other dopamine agonists/antagonists: Combination therapy can alter effectiveness or side effects.
• Sleep medicines, opioids, sedatives, and some antihistamines: Combining can increase drowsiness and dizziness.
• Medicines for nausea or mental health: Some medicines that block dopamine receptors may reduce cabergoline’s effectiveness.

Always inform your pharmacist about all medicines you take, including over-the-counter products, herbal supplements, and vitamins.

Dosing (How Cabergoline is Usually Taken)

Dosing varies widely depending on the indication, the severity of prolactin elevation, and individual response (including how prolactin levels change). Your treating clinician will determine your starting dose and any gradual adjustments.

Common dosing patterns

• Hyperprolactinaemia/prolactinomas: Often started at a low dose to reduce side effects, then titrated based on prolactin levels and symptom response.
• Titration: Dose changes may occur over weeks to reach the most effective and well-tolerated dose.

What to monitor during dose adjustments

• Prolactin blood tests (to confirm the medicine is working)
• Symptoms (e.g., menstrual regularity, sexual function, headaches/visual symptoms if tumour-related)
• Tolerability (e.g., dizziness, nausea, fatigue)

Do not change your dose without medical advice. Because many dosing schedules are weekly, small changes can matter.

Practical Use Tips (Making Treatment Easier)

• Use a reminder: Set a weekly alarm/calendar reminder for your dose day.
• Keep a symptom note: Track side effects (nausea, dizziness, sleepiness) and how symptoms improve. This can help your clinician fine-tune dosing.
• Stand up slowly: If you feel light-headed, move slowly from sitting/lying to standing.
• Plan around driving: If you feel drowsy, avoid driving or operating machinery until you’re sure you’re alert.
• Attend follow-ups: Regular blood tests and (when relevant) scans or assessments help confirm safety and effectiveness.

Safety Profile and Possible Side Effects

Most people tolerate cabergoline well, but side effects can occur—especially early in treatment or after dose increases. Side effects vary by individual and dose.

Common side effects

• Nausea or stomach discomfort
• Dizziness or light-headedness
• Headache
• Fatigue or sleepiness
• Low blood pressure (particularly when standing)
• Constipation

Less common but important risks

• Heart valve effects (a potential risk, especially with long-term higher-dose use in some populations). Clinicians may monitor with heart assessments depending on your dose and duration.
• Impulse control-related behaviours (e.g., compulsive gambling, shopping, eating, or sexual behaviours) have been reported with dopamine agonists. Seek advice promptly if you notice unusual urges.
• Sudden sleep episodes or severe sleepiness (rare, but serious).
• Psychiatric symptoms including agitation or hallucinations (uncommon).

When to seek urgent medical help

Get urgent medical advice if you experience:

• Fainting, severe dizziness, or signs of a serious allergic reaction (e.g., swelling of face/lips, trouble breathing)
• Chest pain, new breathlessness, or symptoms suggesting heart problems
• Severe confusion, hallucinations, or significant mood changes
• Unusual extreme sleepiness or falling asleep unexpectedly while driving or doing hazardous activities

Guidance on Monitoring (What Your Clinician May Check)

Monitoring helps ensure the medicine is effective and safe.

• Blood tests: prolactin levels to confirm reduction
• Symptoms and physical exam: menstrual status, sexual function, headache and vision symptoms if a pituitary tumour is present
• Heart monitoring (in selected cases): depending on your dose, length of therapy, and medical history, clinicians may consider echocardiography or other assessments
• Other hormone tests: if tumour-related hormone imbalance is suspected

Tip: Ask your healthcare provider what monitoring schedule applies to you.

Recent Guidance and Clinical Considerations in Australia

In Australia, cabergoline is widely used in clinical practice for prolactin-related conditions. Guidance typically emphasises:

• Starting at a low dose and gradually adjusting to reduce adverse effects
• Regular monitoring of prolactin and symptoms to confirm response
• Individualised assessment of heart valve risk, particularly for longer-term therapy and higher cumulative exposure
• Patient education about dizziness, driving safety, and impulse control changes

Local practice may also reflect updates from specialist endocrinology reviews and safety communications. If you would like, you can ask your pharmacist what monitoring or follow-up is recommended for your particular dosing regimen.

Alternative Options

Depending on your diagnosis and personal circumstances, alternative treatments may be considered. Options can include:

• Other dopamine agonists (e.g., medicines in the same class such as quinagolide or bromocriptine, depending on availability and suitability)
• Transsphenoidal surgery for selected pituitary tumour cases
• Radiation therapy in specific situations (typically later-line or when surgery/medical therapy is insufficient)
• Other endocrine therapies for different underlying causes of hyperprolactinaemia

The best alternative depends on the cause of high prolactin (for example, tumour-related vs medication-related vs other medical conditions), your symptom needs, and your tolerance of treatment.

Market and Legal Context (Australia)

In Australia, cabergoline is regulated under national medicines and pharmacy standards. It is supplied through appropriate channels and is generally subject to healthcare oversight to ensure safe use.

• Availability: Cabergoline is available through prescription medicine pathways in Australia.
• Quality and supply: Online pharmacies should supply medicines from authorised distribution networks and follow applicable legal and safety requirements.
• Safety practices: You should receive guidance on correct dosing, possible interactions, and side effect monitoring.

Delivery: Availability can vary by strength and supply chain timing. If you need a specific tablet strength, place your order with enough lead time for planned follow-up.

Delivery and Availability (Online Pharmacy Considerations)

When ordering online in Australia, consider the following:

• Tablet strength matters: Confirm you are ordering the correct strength and quantity.
• Packaging: Medicines should arrive in protective packaging with clear labelling.
• Cold chain: Cabergoline tablets typically do not require refrigeration, but always check the product storage instructions on the label.
• Delivery times: Delivery timeframes depend on location and supplier dispatch schedules.

If you have questions about stock availability, delivery timing, or whether a particular strength is currently in supply, contact customer support or your pharmacist before placing the order.

Storage Information

• Store tablets at room temperature unless the label states otherwise.
• Keep in the original packaging to protect from moisture and to identify the tablet strength.
• Keep out of reach of children.
• Check the expiry date before use and do not take expired tablets.

FAQ — Cabergoline

1) What is cabergoline used for?

Cabergoline is commonly used to treat high prolactin (hyperprolactinaemia) and prolactin-related conditions, including prolactin-secreting pituitary tumours. It reduces prolactin by activating dopamine receptors.

2) How quickly will I feel better?

Some people notice symptom improvement within days to weeks, but it may take several weeks for prolactin levels and symptoms to stabilise. Your clinician will usually plan repeat blood tests to track your response.

3) Do I take cabergoline daily?

Many patients take cabergoline once or twice weekly for prolactin-related conditions. Your exact schedule depends on your diagnosis and dose plan—follow your personalised instructions.

4) Can I take cabergoline with food?

Cabergoline can typically be taken with or without food. If nausea occurs, taking it with food may improve comfort.

5) What should I do if I miss a dose?

Because cabergoline is often taken weekly, do not double up. The right approach depends on how close you are to the next dose—contact your pharmacist or clinician for personalised advice.

6) Can I drink alcohol while taking cabergoline?

Alcohol can worsen dizziness or sleepiness. It’s best to limit or avoid alcohol until you know how cabergoline affects you.

7) What medicines should I avoid?

Some medicines may affect cabergoline’s effectiveness or increase side effects. In particular, tell your pharmacist about blood pressure medicines, sedatives, and medicines that affect dopamine pathways.

8) Are there serious side effects I should watch for?

Seek urgent advice for severe symptoms such as fainting, breathing difficulties, chest pain, severe confusion, or unexpected extreme sleepiness. With longer-term use and higher exposure, healthcare providers may monitor heart valve health in selected patients.

9) Will cabergoline affect driving?

Cabergoline may cause dizziness or drowsiness in some people. Avoid driving or operating machinery if you feel affected. If you experience sudden sleepiness, stop driving and seek medical advice urgently.

10) Are there alternatives to cabergoline?

Depending on your condition, alternatives may include other dopamine agonists, surgery, or other specialist treatments. Your doctor can advise the most appropriate option based on your diagnosis and medical history.

Summary

Cabergoline is a dopamine agonist used primarily to lower prolactin and manage prolactin-related conditions. It is often taken on a weekly schedule, and its effects can develop over weeks. Like all medicines, it has potential side effects—commonly nausea, dizziness, and headache—while less common but important risks (including heart valve effects and impulse control changes) require awareness and monitoring in appropriate circumstances.

If you have questions about dosing, interactions, or what monitoring is recommended for you, speak with a pharmacist or healthcare professional. For online ordering, confirm the correct tablet strength and plan ahead for delivery timing.